Daigo Jointic (Capsules) Instructions for Use
Marketing Authorization Holder
Metabiotic, LLC (Russia)
Manufactured By
PNK Farmaceutici, S.p.A. (Italy)
Contact Information
B and S Corporation Co. Ltd. (Japan)
Dosage Form
| Daigo Jointic | Capsules: 60 pcs. |
Dosage Form, Packaging, and Product Composition
Capsules with a mass of 0.584 g.
| 2 caps. | |
| Chlorella peptide IPH C | 140 mg |
| L-Glutamine | 52.5 mg |
| L-Isoleucine | 52.5 mg |
| L-leucine | 52.5 mg |
| L-arginine hydrochloride | 52.5 mg |
| Palmitoylethanolamide | 325 mg |
| Lipolytic enzymes (lipases) | 200 mg |
| Ascorbic acid (vit. C) | 50 mg |
| Boron | 0.662 mg |
| Manganese | 2 mg |
| Chromium | 0.05 mg |
15 pcs. – blisters (4) – cardboard packs.
Therapeutic Category
Dietary supplement for supporting the function of the musculoskeletal system
Properties
The components included in the composition of Daigo Jointic contribute to the improvement of joint function, strengthening of cartilage, bone, and muscle tissue.
The preparation increases physical endurance and training effectiveness.
The preparation is suitable as an additional means for rehabilitation in terms of joint pathology, for strengthening joints in people with excess body weight.
The preparation can also be used after a period of forced hypodynamia (for example, due to injuries, after infectious diseases, etc.).
Scope of Application
Of the Daigo Jointic product
- As a dietary supplement – a source of Chlorella peptide IPH C, L-glutamic acid, L-isoleucine, L-leucine, L-arginine, palmitoylethanolamide, vitamin C, boron, manganese, chromium, lipase enzyme.
ICD codes
| ICD-10 code | Indication |
| E63 | Other nutritional deficiencies |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Orally, with meals.
Adults take 1 capsule 2 times/day. The duration of administration is 1 month. If necessary, the course can be repeated.
Side Effects
None identified.
Contraindications
- Individual intolerance to the product components;
- Pregnancy;
- Breastfeeding period.
Use During Pregnancy and Breastfeeding
Use during pregnancy and breastfeeding is contraindicated.
Special Instructions
A dietary supplement, not a medicinal product.
It is recommended to consult a doctor before use.
Dispensing Status
Places of sale are determined by the national legislation of the member states of the Eurasian Economic Union.
Storage Conditions
The product should be stored in a dry place, protected from direct sunlight, out of reach of children, at a temperature not exceeding 25°C (77°F).
Shelf Life
Shelf life – 5 years from the date of manufacture.
After opening, store tightly closed under the same conditions.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Daivobet, ointment, 30g
Arbidol, capsules 100mg, 40pcs
Mildronate capsules 500mg, 90pcs
Phenibut-Vertex pills 250mg, 20pcs
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs
Fenotropil pills 100mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Kagocel pills 12mg, 30pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Ingavirin capsules 90mg, 10pcs 